ArticleInvestigative ophthalmology & visual science2025
Transcriptomic Profiling of Orbital Fat Tissue and Ocular Surface Wash in Active Thyroid Eye Disease Requiring Urgent Orbital Decompression.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Thyroid eye disease (TED) is an autoimmune disorder characterized by orbital inflammation and tissue remodeling. Although most patients with active TED respond to medical therapy, a subset develops sight-threatening complications which require urgent orbital decompression when conservative treatment fails. This study aimed to elucidate the molecular mechanisms underlying active, moderate-to-severe TED in patients requiring urgent orbital decompression during the active disease stage. Methods: Transcriptomic profiling was performed on retro-orbital fat samples from 13 patients and ocular surface wash samples from 9 patients undergoing urgent orbital decompression, as well as on samples from control subjects. Differential gene expression, pathway enrichment, cell-type composition, and drug-gene interactions were analyzed. Results: In retro-orbital fat, the majority of differentially expressed genes were upregulated, predominantly mapping to immune system, with a pronounced neutrophilic signature including degranulation and extracellular trap formation. Increased infiltration of neutrophils, B cells, and T cells was observed, whereas ocular surface wash samples exhibited a largely downregulated immune signature, reflecting compartment-specific immune responses. Expression of several transcripts from ocular surface wash correlated with patients' disease activity, suggesting potential use as noninvasive biomarkers with CD151, MAST4, and HPCAL1 genes correlating best. Drug-gene interaction analysis nominated JAK and BTK inhibitors as candidate therapeutics in TED. Conclusions: This study provides a unique molecular atlas of active, moderate-to-severe TED environment, uncovers the active role of neutrophils in TED pathogenesis, and identifies candidate therapeutic targets and noninvasive biomarkers that may inform future clinical strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.